Oncologianova GmbH Gesellschaft fuer Innovationen in der Onkologie

Recklinghausen 4 trials

4 Registered trials

0 Currently recruiting

Organisation

Oncologianova GmbH Gesellschaft fuer Innovationen in der Onkologie

Location

Recklinghausen, Germany

Identifier

ORG-100044151

Address

Am Stadion 9, Hillerheide, 45659, Germany

Departments

Oncologianova GmbH Gesellschaft fuer Innovationen in der Onkologie
Onkologie
Praxis

Clinical trials at this site (4)

Search interface

Sacituzumab Govitecan in primary HER2-negative breast cancer (SASCIA) Ended

2023-510390-33-00 HER2-negative breast cancer patients with high relapse 5 2020-10-23
Adjuvant Dynamic marker - Adjusted Personalized Therapy comparing endocrine therapy plus ribociclib versus chemotherapy in intermediate-risk… Ended

2024-515769-32-00 HR+/HER2- early breast cancer 5 2019-07-02
Olaparib as adjuvant treatment in patients with germline BRCA mutated high risk HER2negative primary breast cancer. Ended

2024-511096-15-00 Breast Cancer 5 2014-08-01
A Randomized, Double-Blind, Phase III Clinical Trial of Neoadjuvant Chemotherapy with Atezolizumab or Placebo in Patients with Triple-Negati… Ended

2023-508472-11-00 Patients with early breast cancer 5 2018-06-13